What happens to estrogen after menopause?
Direct Answer
After menopause, the ovaries cease most of their estrogen production, and levels drop significantly and permanently. The body continues to produce small amounts of estrogen by converting androgens (from the adrenal glands and ovaries) into estrogen in adipose (fat) tissue and other organs.
Detailed Explanation
The postmenopausal state is characterized by a permanent low-estrogen environment. While the ovaries no longer produce the high levels of estradiol (E2) seen during the reproductive years, the body does not become entirely "estrogen-free."
The primary form of estrogen after menopause is estrone (E1), which is weaker than the estradiol produced by the ovaries. This estrone is produced through a process called "peripheral aromatization." The adrenal glands and the ovaries continue to produce androgens (like androstenedione and testosterone). An enzyme called aromatase, found in fat tissue, muscle, and the brain, converts these androgens into estrone.
This is why women with a higher body mass index (BMI) often have slightly higher levels of circulating estrogen after menopause, as they have more adipose tissue to perform this conversion. However, these levels are still a fraction of what they were before the transition and are generally not enough to protect the bones or heart or to prevent symptoms like vaginal dryness.
The loss of estradiol has systemic effects because estrogen receptors are located throughout the body. In the brain, lower estrogen affects temperature regulation, mood, and cognitive function. In the bones, it leads to an increase in bone resorption (breakdown), which can lead to osteoporosis if not managed. In the skin, it leads to a decrease in collagen and elasticity, resulting in thinning and wrinkling. In the genitourinary tract, it causes the tissues to become thinner, less lubricated, and more prone to infection—a condition known as the Genitourinary Syndrome of Menopause (GSM).
Furthermore, the loss of estrogen impacts the cardiovascular system by increasing arterial stiffness and changing cholesterol patterns. This makes the postmenopausal years a critical time for monitoring heart health.
Understanding that estrogen remains low permanently is key to long-term health planning. While some symptoms like hot flashes may eventually stop as the brain adapts to the new baseline, the "silent" impacts on the skeleton and cardiovascular system continue. This is why postmenopausal health focuses on "estrogen-independent" ways to support these systems, such as resistance training to build bone and muscle, heart-healthy nutrition, and maintaining a healthy weight.
For many women, the use of local vaginal estrogen is a long-term necessity to maintain urogenital health, as these tissues do not "adapt" to low estrogen in the same way the brain's thermostat does.
In summary, postmenopause is a new biological baseline. By understanding what happens to estrogen and how the body compensates, women can take proactive steps to ensure they remain healthy and vibrant in the decades following the transition.
Evidence Context
We distinguish between "ovarian estrogen" (estradiol) and "peripheral estrogen" (estrone). We prioritize research that looks at the systemic impact of this permanent shift. Emerging research is investigating "tissue-specific" estrogen production and whether some organs can produce their own local supply of estrogen even when blood levels are low.